Comparative evaluation of two doses of Mifepristone (10 mg vs 25 mg) in the management of symptoms of uterine fibroid
Not Applicable
- Conditions
- Health Condition 1: D259- Leiomyoma of uterus, unspecified
- Registration Number
- CTRI/2019/11/021934
- Lead Sponsor
- Kavita Agarwal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients 18-50 years with symptomatic fibroid
Fibroid less than 15 cm
Patients willing to sign informed consent and to undergo ultrasonography at 3 months
Patient willing to come for follow up at 3 months and 6 months
Exclusion Criteria
Fibroid more than 15 cm
Fibroid with severe anemia needing blood transfusion
Fibroid with pressure symptoms
Fibroid wanting immediate surgery
Fibroid with pregnancy
Patient not willing to come for follow up
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method